Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 807 results for "Treatment For Multiple Sclerosis"

Raising Awareness on Multiple Sclerosis
New Indian Express

Novartis launches 24 Life Hacks in 24 hours showing commitment...

Novartis joins the global Multiple Sclerosis (MS) community today in recognition of World MS Day, with its 24 Life Hacks in 24 Hours initiative. Today people with MS can check out a range of top tips from the #MSLifeHacks campaign where one helpful ... News-Medical.Net, 2 days ago
Raising Awareness on Multiple Sclerosis New Indian Express, 3 days ago
[x]  

12 images for Treatment For Multiple Sclerosis

MDLinx, 1 day ago
Medical Xpress, 3 weeks ago
Pharmaceutical Journal, 1 month ago
NewsReality.com, 3 weeks ago
NewsReality.com, 1 week ago
World Future Society, 1 week ago
World Future Society, 1 week ago
WABE, 4 weeks ago
Warwick Daily News, 1 month ago
Pittsburgh Post-Gazette, 1 month ago
Globes

Mapi Pharma Picks Up $10M for Long-Acting MS Treatment

Mapi Pharma Ltd ., an Israeli biotechnology company working on a product that could enable sufferers of multiple sclerosis to be treated with an injection once a month instead of every day, has raised $10 million in new funding as it moves into ...
 Dow Jones Financial Information Services3 days ago MS treatment developer Mapi Pharma raises $10m  Globes3 days ago

Genzyme unveils AUBAGIO 14 mg as a first-line once daily oral tablet for treating relapsing remitting multiple sclerosis in Canada

Genzyme announced on Monday the addition of AUBAGIO 14 mg on the provincial drug formulary as a first-line once daily oral tablet for treating people living with relapsing remitting multiple sclerosis (RRMS) in Canada through PEI Pharmacare. The ...
 Bloomberg4 days ago

Ontario Reimburses CIS Indication for REBIF®, a First-Line Treatment for Multiple Sclerosis

Rebif now reimbursed under Ontario Drug Benefit Program for treatment of patients with Clinically Isolated Syndrome (CIS) MISSISSAUGA, ON, May 25, 2015 /CNW/ - Today, EMD Serono a Division of EMD Inc., Canada, a subsidiary of Merck KGaA, Darmstadt, ...
 Canada NewsWire4 days ago

New therapy could halt multiple sclerosis progress

MONTREAL, May 20 (UPI) -- Researchers at the University of Montreal have discovered a treatment that can potentially stop the progression of multiple sclerosis. The melanoma cell adhesion molecule, or MCAM, was found to be a crucial element in the ...
 UPI1 week ago Researchers have discovered a treatment that can halt the progress of multiple sclerosis and possibly stop it after its earliest symptoms appear.  TickerTech.com1 week ago

Prince Edward Island funds treatment with AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Once-daily oral medication to be reimbursed for first-line use MISSISSAUGA, ON , May 25, 2015 /CNW/ - Genzyme, a Sanofi company, announced today that PEI Pharmacare has included AUBAGIO (teriflunomide) 14 mg on the provincial drug formulary as a ...
 Industrial Info Financials5 days ago GENZYME : Reports Prince Edward Island Funds Treatment with AUBAGIO  4 Traders1 day ago PEI funds treatment with Aubagio for relapsing remitting multiple sclerosis  Pharmaceutical Business Review3 days ago
[x]  

Discovery of a treatment to block the progression of multiple sclerosis

A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have ...
 CPhI.cn3 days ago An important step towards a treatment to block the progression of multiple sclerosis (MS) through a successful partnership between researchers, university and a biotech company  Canada NewsWire1 week ago
[x]  

Genzyme collaborates with Ablynx on multiple sclerosis project

22-May-2015 Biotechnology | Research Ablynx has entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate Nanobodies against a target that plays an important role in multiple sclerosis (MS) and ...
 Manufacturing Chemist1 week ago GENZYME TO COLLABORATE WITH ABLYNX ON MULTIPLE SCLEROSIS RESEARCH PROJECT  FierceBiotech1 week ago Ablynx, Genzyme collaborate on multiple sclerosis research project  Pharmaceutical Business Review1 week ago Genzyme, Ablynx collaborate on multiple sclerosis research project  Center Watch1 week ago
[x]  
Med India

Results of Multiple Sclerosis Drug Trail to be Presented at Neurology Annual Meeting

MedDay, a biotechnology company focused on the treatment of nervous system disorders, will present results of its pivotal clinical trial at The American Academy of Neurology (AAN) annual meeting in Washington DC, on April 24. The trail investigates the ...
 Med India1 month ago
Monthly Prescribing Reference

Study implicates new gene in multiple sclerosis disease activity

Genetic variant predicts likelihood of patient's response to treatment A new study led by investigators at Brigham and Women's Hospital (BWH) reports the discovery of a genetic variant that is associated with a patient's likelihood of ...
 Medical News Today2 weeks ago MS Gene Variant May Affect Treatment Response  Monthly Prescribing Reference4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less